Veracyte Inc (NASDAQ: VCYT) is -30.21% lower on its value in year-to-date trading and has touched a low of $18.73 and a high of $30.52 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VCYT stock was last observed hovering at around $18.86 in the last trading session, with the day’s gains setting it 0.34%.
Currently trading at $19.20, the stock is -7.32% and -14.47% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing 1.80% at the moment leaves the stock -21.52% off its SMA200. VCYT registered -15.94% loss for a year compared to 6-month gain of -10.78%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -11.40% loss in the last 1 month and extending the period to 3 months gives it a -24.85%, and is -7.38% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.70% over the week and 3.75% over the month.
Veracyte Inc (VCYT) has around 815 employees, a market worth around $1.44B and $361.05M in sales. Profit margin for the company is -20.61%. Distance from 52-week low is 2.51% and -37.09% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.08%).
The EPS is expected to grow by 74.77% this year
The shares outstanding are 75.07M, and float is at 73.81M with Short Float at 4.93%.
Veracyte Inc (VCYT) Insider Activity
The most recent transaction is an insider sale by EASTHAM KARIN, the company’s Director. SEC filings show that EASTHAM KARIN sold 10,000 shares of the company’s common stock on Apr 01 ’24 at a price of $21.65 per share for a total of $0.22 million. Following the sale, the insider now owns 33125.0 shares.
Veracyte Inc disclosed in a document filed with the SEC on Mar 01 ’24 that JONES EVAN/ FA (Director) sold a total of 10,000 shares of the company’s common stock. The trade occurred on Mar 01 ’24 and was made at $24.36 per share for $0.24 million. Following the transaction, the insider now directly holds 37601.0 shares of the VCYT stock.
Still, SEC filings show that on Jul 19 ’23, JONES EVAN/ FA (Director) disposed off 3,090 shares at an average price of $30.17 for $93232.0. The insider now directly holds 35,173 shares of Veracyte Inc (VCYT).
